Document is current
Any future updates will be listed below
-
Authors
Giannoccaro, Maria Pia https://orcid.org/0000-0003-2208-376X
Vacchiano, Veria
Leone, Marta
Camilli, Federico
Zenesini, Corrado
Panzera, Ivan
Balboni, Alice
Tappatà, Maria
Borghi, Annamaria
Salvi, Fabrizio
Lugaresi, Alessandra
Rinaldi, Rita
Di Felice, Giulia
Lodi, Vittorio
Lazzarotto, Tiziana
Liguori, Rocco
,
Donadio, Vincenzo
Avoni, Patrizia
D’Angelo, Roberto
Ricciardiello, Fortuna
Masullo, Marco
De Marco, Giovanna
Salvi, Filippo
Zini, Andrea
Galletti, Margherita
Biundo, Giampaolo
Pastorelli, Francesca
Michelucci, Roberto
- License Information
-
More Information
Article History
Received: 13 January 2022
Revised: 11 April 2022
Accepted: 12 April 2022
First Online: 3 May 2022
Declarations
:
: MPG, VV, ML, FC, CZ, IP, AB, MT, AB, FS, RR, GDF, VL, TZ, declare no competing interest; AL, has served as a Biogen, Bristol Myers Squibb, Merck Serono, Novartis, Roche, Sanofi/ Genzyme and Teva Advisory Board Member. She received congress and travel/accommodation expense compensations or speaker honoraria from Biogen, Merck, Mylan, Novartis, Roche, Sanofi/Genzyme, Teva and Fondazione Italiana Sclerosi Multipla (FISM). Her institutions received research grants from Novartis and Sanofi Genzyme. RL has received: Lecture fees from LT3 s.r.l., NICO s.r.l., SUMMEET s.r.l. and GALEN SYMPOSION s.r.o.; fees for consultancy (Advisory Board) from LT3 s.r.l. and PREX s.r.l.; fees for scientific meeting organization from I&C s.r.l.; Chair meeting fees from PLANNING CONGRESSI s.r.l.
Free to read: This content has been made available to all.
